Abstract:Importance The X chromosome has remained enigmatic in Alzheimer disease (AD), yet it makes up 5% of the genome and carries a high proportion of genes expressed in the brain, making it particularly appealing as a potential source of unexplored genetic variation in AD. Objectives To perform the first large-scale X chromosome–wide association study (XWAS) of AD. Design, Setting, and Participants This was a meta-analysis of genetic association studies in case-control, family-based, population-based, and longitudinal AD-related cohorts from the US Alzheimer's Disease Genetics Consortium, the Alzheimer's Disease Sequencing Project, the UK Biobank, the Finnish health registry, and the US Million Veterans Program. Risk of AD was evaluated through case-control logistic regression analyses. Data were analyzed between January 2023 and March 2024. Genetic data available from high-density single-nucleotide variant microarrays and whole-genome sequencing and summary statistics for multitissue expression and protein quantitative trait loci available from published studies were included, enabling follow-up genetic colocalization analyses. A total of 1 629 863 eligible participants were selected from referred and volunteer samples, 477 596 of whom were excluded for analysis exclusion criteria. The number of participants who declined to participate in original studies was not available. Main Outcome and Measures Risk of AD, reported as odds ratios (ORs) with 95% CIs. Associations were considered at X chromosome–wide ( P < 1 × 10 −5 ) and genome-wide ( P < 5 × 10 −8 ) significance. Primary analyses are nonstratified, while secondary analyses evaluate sex-stratified effects. Results Analyses included 1 152 284 participants of non-Hispanic White, European ancestry (664 403 [57.7%] female and 487 881 [42.3%] male), including 138 558 individuals with AD. Six independent genetic loci passed X chromosome–wide significance, with 4 showing support for links between the genetic signal for AD and expression of nearby genes in brain and nonbrain tissues. One of these 4 loci passed conservative genome-wide significance, with its lead variant centered on an intron of SLC9A7 (OR, 1.03; 95% CI, 1.02-1.04) and colocalization analyses prioritizing both the SLC9A7 and nearby CHST7 genes. Of these 6 loci, 4 displayed evidence for escape from X chromosome inactivation with regard to AD risk. Conclusion and Relevance This large-scale XWAS of AD identified the novel SLC9A7 locus. SLC9A7 regulates pH homeostasis in Golgi secretory compartments and is anticipated to have downstream effects on amyloid β accumulation. Overall, this study advances our knowledge of AD genetics and may provide novel biological drug targets. The results further provide initial insights into elucidating the role of the X chromosome in sex-based differences in AD.

Eight quick tips for including chromosome X in genome-wide association studies

Genome-wide association testing beyond SNPs

Research Strategies for the Next Step of Genome-Wide Association Study

XCMAX4: A Robust X Chromosomal Genetic Association Test Accounting for Covariates

Chromosome X-wide association study in case control studies of pathologically confirmed Alzheimer's disease in a European population

Comprehensive whole-genome analyses of the UK Biobank reveal significant sex differences in both genotype missingness and allele frequency on the X chromosome

Genome-wide association studies: theoretical and practical concerns

Implication of Next-Generation Sequencing on Association Studies

No Association of Coronary Artery Disease with X-Chromosomal Variants in Comprehensive International Meta-Analysis.

Analytical Strategies to Include the X-chromosome in Variance Heterogeneity Analyses: Evidence for Trait-Specific Polygenic Variance Structure

Chromosome X-wide analysis of positive selection in human populations: from common and private signals to selection impact on inactivated genes and enhancers-like signatures

Current Status of Genome-Wide Association Study

Translation of genome-wide association study: from genomic signals to biological insights

Chromosome X-wide Analysis of Positive Selection in Human Populations: Common and Private Signals of Selection and its Impact on Inactivated Genes and Enhancers

Beyond guilty by association at scale: searching for causal variants on the basis of genome-wide summary statistics

Benefits and limitations of genome-wide association studies

Role of the X Chromosome in Alzheimer Disease Genetics

Inferring genes that escape X-Chromosome inactivation reveals important contribution of variable escape genes to sex-biased diseases

From GWAS to Gene: Transcriptome-Wide Association Studies and Other Methods to Functionally Understand GWAS Discoveries

Chapter 10: Mining Genome-Wide Genetic Markers

Small-group originating model: Optimized individual-level GWAS simulation featured by SLiM and using open-access data